Pacific Biosciences Revenue and Competitors

Location

$1.3B

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Pacific Biosciences's estimated annual revenue is currently $121.6M per year.(i)
  • Pacific Biosciences's estimated revenue per employee is $142,758
  • Pacific Biosciences's total funding is $1.3B.
  • Pacific Biosciences's current valuation is $2.7B. (January 2022)

Employee Data

  • Pacific Biosciences has 852 Employees.(i)
  • Pacific Biosciences grew their employee count by 9% last year.

Pacific Biosciences's People

NameTitleEmail/Phone
1
CEO & PresidentReveal Email/Phone
2
VP, SoftwareReveal Email/Phone
3
VP and General ManagerReveal Email/Phone
4
VP Engineering DevelopmentReveal Email/Phone
5
VP, Chips DevelopmentReveal Email/Phone
6
VP Customer ExperienceReveal Email/Phone
7
VP Intellectual PropertyReveal Email/Phone
8
VP DevelopmentReveal Email/Phone
9
VP, SoftwareReveal Email/Phone
10
VP, Intellectual PropertyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12M3626%$208.1MN/A
#2
$434.8M1865-14%$2B$2.7B
#3
$4280M11139-4%$28M$63.3B
Add Company

What Is Pacific Biosciences?

Pacific Biosciences (PacBio), headquartered in Menlo Park, CA, is a startup biotechnology company developing a transformative Single Molecule Real Time (SMRT™) DNA sequencing platform. PacBio’s goal is to commercialize SMRT DNA sequencing technology, eventually enabling sequencing of individual genomes as part of routine medical care. The company is currently venture funded by Kleiner Perkins Caufield & Byers, Mohr Davidow Ventures, Alloy Ventures, Maverick Capital, and others.

keywords:N/A

$1.3B

Total Funding

852

Number of Employees

$121.6M

Revenue (est)

9%

Employee Growth %

$2.7B

Valuation

N/A

Accelerator

Pacific Biosciences News

2022-04-17 - Children's Mercy Test Drives Addition of Methylation Calls on ...

NEW YORK – Researchers at Children's Mercy Kansas City are among the first to try out a new capability from Pacific Biosciences: the ability...

2022-03-30 - Pacific Biosciences, Corteva Agriscience Collaborate on High ...

NEW YORK – Pacific Biosciences said on Monday that it is collaborating with Corteva Agriscience to develop custom workflows for plant, pest,...

2022-03-30 - Pacific Biosciences Hit By Sentiment, But The Future Of Long-Read Sequencing Is Strong

Pacific Biosciences Hit By Sentiment, But The Future Of Long-Read Sequencing Is Strong · Summary · Another Step Toward The Ag Opportunity · Expect...

2011-02-02 - Pacific Biosciences scores patent win over Life Technologies

Pacific Biosciences of California Inc. (NSDQ:PACB) won a favorable decision from the U.S. Patent Office over a competitor. The Menlo Park, Calif.-based company began a "patent interference" process against Life Technologies Corp. (NSDQ:LIFE) in March 2009 regarding patent claims by both compani ...

2010-07-14 - Pacific Biosciences Completes $109M Series F Financing Round

Pacific Biosciences, a Menlo Park, California-based company developing a technology platform for real-time detection of biological events at single molecule resolution, has completed a $109m Series F financing round. The round also includes a previously announced $50m strategic investment by Ge ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$278.3M984-31%N/A
#2
$75M9880%N/A
#3
$300M11819%$2B
#4
$262.5M129354%N/A
#5
$226.3M1347N/AN/A